Amgen Inc (AMGN) stock

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value

$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Earnings

Amgen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 3, 2026

Q3 FY2026 · estimated, during market hours

Revenue, Q2 FY2026

$10.10B

+9.8% on a year earlier

Non-GAAP EPS, Q2 FY2026

$6.29

$6.02 a year earlier

Latest guidance

Raised

Aug 4, 2026 · 7 items

Quarterly results

Revenue and earnings per share from each of Amgen's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 3, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Aug 4, 2026during market hours	$10.10B	+9.8%	$4.37	$6.29	Release
Q1 FY2026ended Mar 31, 2026	Apr 30, 2026during market hours	$8.60B	+6.2%	$3.34	$5.15	Release
Q4 FY2025ended Dec 31, 2025	Feb 3, 2026during market hours	$9.90B	+8.8%	$2.45	$5.29	Release
Q3 FY2025ended Sep 30, 2025	Nov 4, 2025during market hours	$9.60B	+12.9%	$5.93	$5.64	Release
Q2 FY2025ended Jun 30, 2025	Aug 5, 2025during market hours	$9.20B	+9.5%	$2.65	$6.02	Release
Q1 FY2025ended Mar 31, 2025	May 1, 2025during market hours	$8.10B	+9.5%	$3.20	$4.90	Release
Q4 FY2024ended Dec 31, 2024	Feb 4, 2025during market hours	$9.10B	+11.0%	$1.16	$5.31	Release
Q3 FY2024ended Sep 30, 2024	Oct 30, 2024during market hours	$8.50B	+23.2%	$5.22	$5.58	Release
Q2 FY2024ended Jun 30, 2024	Aug 6, 2024during market hours	$8.40B	+20.0%	$1.38	$4.97	Release
Q1 FY2024ended Mar 31, 2024	May 2, 2024during market hours	$7.40B	+21.3%	-$0.21	$3.96	Release
Q4 FY2023ended Dec 31, 2023	Feb 6, 2024during market hours	$8.20B	+20.6%	$1.42	$4.71	Release
Q3 FY2023ended Sep 30, 2023	Oct 31, 2023before the open	$6.90B	+3.0%	$3.22	$4.96	Release
Q2 FY2023ended Jun 30, 2023	Aug 3, 2023during market hours	$7.00B	+6.1%	$2.57	$5.00	Release
Q1 FY2023ended Mar 31, 2023	Apr 27, 2023during market hours	$6.10B	-1.6%	$5.28	$3.98	Release
Q4 FY2022ended Dec 31, 2022	Jan 31, 2023during market hours	$6.80B	0.0%	$3.00	$4.09	Release
Q3 FY2022ended Sep 30, 2022	Nov 3, 2022during market hours	$6.70B	0.0%	$3.98	$4.70	Release
Q2 FY2022ended Jun 30, 2022	Aug 4, 2022during market hours	$6.60B	–	$2.45	$4.65	Release
Q1 FY2022ended Mar 31, 2022	Apr 27, 2022during market hours	$6.20B	–	$2.68	$4.25	Release
Q4 FY2021ended Dec 31, 2021	Feb 7, 2022during market hours	$6.80B	–	$3.36	$4.36	Release
Q3 FY2021ended Sep 30, 2021	Nov 2, 2021during market hours	$6.70B	–	$3.31	$4.67	Release
Q1 FY2021ended Mar 31, 2021	Apr 27, 2021during market hours	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 2, 2021during market hours	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 28, 2020during market hours	–	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Jul 28, 2020during market hours	–	–	–	–	Filing
Q1 FY2020ended Mar 31, 2020	Apr 30, 2020during market hours	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Amgen's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Total revenues	FY2026	$38.20B – $39.40B	$37.10B – $38.50B	Raised	Aug 4, 2026
EPSGAAP	FY2026	$15.80 – $17.08	$15.62 – $17.10	Narrowed	Aug 4, 2026
EPSnon-GAAP	FY2026	$22.30 – $23.50	$21.70 – $23.10	Raised	Aug 4, 2026
Capital expenditures	FY2026	$2.60B	$2.60B	Reaffirmed	Aug 4, 2026
Share repurchases	FY2026	$3.00B	$3.00B	Reaffirmed	Aug 4, 2026
tax rateGAAP	FY2026	14.5% – 16%	14.5% – 16%	Reaffirmed	Aug 4, 2026
tax ratenon-GAAP	FY2026	15% – 16.5%	15% – 16.5%	Reaffirmed	Aug 4, 2026

Guidance vs results

The last range Amgen gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	EPS	$20.60 – $21.40	$21.85Σ4Q	Above range
FY2025	EPS (GAAP)	$13.76 – $14.60	$14.23Σ4Q	Within range
FY2025	Revenue	$35.80B – $36.60B	$36.80BΣ4Q	Above range

Guidance history

Every forecast Amgen put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 4, 2026	Capital expenditures	FY2026	$2.60B	Reaffirmed
Aug 4, 2026	EPS	FY2026	$22.30 – $23.50	Raised
Aug 4, 2026	EPS	FY2026	$15.80 – $17.08	Narrowed
Aug 4, 2026	tax rate	FY2026	14.5% – 16%	Reaffirmed
Aug 4, 2026	tax rate	FY2026	15% – 16.5%	Reaffirmed
Aug 4, 2026	Share repurchases	FY2026	$3.00B	Reaffirmed
Aug 4, 2026	Total revenues	FY2026	$38.20B – $39.40B	Raised
Apr 30, 2026	Capital expenditures	FY2026	$2.60B	Reaffirmed
Apr 30, 2026	EPS	FY2026	$21.70 – $23.10	Raised
Apr 30, 2026	EPS	FY2026	$15.62 – $17.10	Raised
Apr 30, 2026	tax rate	FY2026	14.5% – 16%	Lowered
Apr 30, 2026	tax rate	FY2026	15% – 16.5%	Lowered
Apr 30, 2026	Share repurchases	FY2026	$3.00B	Reaffirmed
Apr 30, 2026	Total revenues	FY2026	$37.10B – $38.50B	Raised
Feb 3, 2026	Capital expenditures	FY2026	$2.60B	New
Feb 3, 2026	EPS	FY2026	$21.60 – $23.00	New
Feb 3, 2026	EPS	FY2026	$15.45 – $16.94	New
Feb 3, 2026	tax rate	FY2026	15.5% – 17%	New
Feb 3, 2026	tax rate	FY2026	16% – 17.5%	New
Feb 3, 2026	Share repurchases	FY2026	$3.00B	New
Feb 3, 2026	Total revenues	FY2026	$37.00B – $38.40B	New
Nov 4, 2025	Capital expenditures	FY2025	$2.20B – $2.30B	Lowered
Nov 4, 2025	EPS	FY2025	$20.60 – $21.40	Raised
Nov 4, 2025	EPS	FY2025	$13.76 – $14.60	Raised
Nov 4, 2025	tax rate	FY2025	14.5% – 16%	Raised
Nov 4, 2025	tax rate	FY2025	15% – 16.5%	Raised
Nov 4, 2025	Share repurchases	FY2025	$500.00M	New
Nov 4, 2025	Total revenues	FY2025	$35.80B – $36.60B	Raised
Aug 5, 2025	Capital expenditures	FY2025	$2.30B	New
Aug 5, 2025	EPS	FY2025	$20.20 – $21.30	New
Aug 5, 2025	EPS	FY2025	$10.97 – $12.11	New
Aug 5, 2025	tax rate	FY2025	11% – 12.5%	New
Aug 5, 2025	tax rate	FY2025	14.5% – 16%	New
Aug 5, 2025	Total revenues	FY2025	$35.00B – $36.00B	New
May 1, 2025	Capital expenditures	FY2025	$2.30B	Reaffirmed
May 1, 2025	EPS	FY2025	$20.00 – $21.20	Reaffirmed
May 1, 2025	EPS	FY2025	$12.21 – $13.46	Raised
May 1, 2025	tax rate	FY2025	11% – 12.5%	Reaffirmed
May 1, 2025	tax rate	FY2025	14.5% – 16%	Lowered
May 1, 2025	Share repurchases	FY2025	$500.00M	Reaffirmed
May 1, 2025	Total revenues	FY2025	$34.30B – $35.70B	Reaffirmed
Feb 4, 2025	Capital expenditures	FY2025	$2.30B	New
Feb 4, 2025	EPS	FY2025	$20.00 – $21.20	New
Feb 4, 2025	EPS	FY2025	$10.89 – $12.14	New
Feb 4, 2025	tax rate	FY2025	11% – 12.5%	New
Feb 4, 2025	tax rate	FY2025	15% – 16%	New
Feb 4, 2025	Share repurchases	FY2025	$500.00M	New
Feb 4, 2025	Total revenues	FY2025	$34.30B – $35.70B	New
Oct 30, 2024	Capital expenditures	FY2024	$1.30B	Reaffirmed
Oct 30, 2024	EPS	FY2024	$19.20 – $20.00	Narrowed
Oct 30, 2024	EPS	FY2024	$8.71 – $9.56	Raised
Oct 30, 2024	tax rate	FY2024	9% – 10.5%	Raised
Oct 30, 2024	tax rate	FY2024	14% – 15%	Lowered
Oct 30, 2024	Share repurchases	FY2024	$500.00M	Reaffirmed
Oct 30, 2024	Total revenues	FY2024	$33.00B – $33.80B	Raised
Aug 6, 2024	Capital expenditures	FY2024	$1.30B	Raised
Aug 6, 2024	EPS	FY2024	$19.10 – $20.10	Narrowed
Aug 6, 2024	EPS	FY2024	$6.57 – $7.62	Lowered
Aug 6, 2024	tax rate	FY2024	6% – 7.5%	Lowered
Aug 6, 2024	tax rate	FY2024	15% – 16%	Reaffirmed
Aug 6, 2024	Share repurchases	FY2024	$500.00M	New
Aug 6, 2024	Total revenues	FY2024	$32.80B – $33.80B	Raised
May 2, 2024	Capital expenditures	FY2024	$1.10B	Reaffirmed
May 2, 2024	EPS	FY2024	$19.00 – $20.20	Narrowed
May 2, 2024	EPS	FY2024	$7.15 – $8.40	Lowered
May 2, 2024	tax rate	FY2024	9.5% – 11%	Lowered
May 2, 2024	tax rate	FY2024	15% – 16%	Lowered
May 2, 2024	Total revenues	FY2024	$32.50B – $33.80B	Raised
Feb 6, 2024	Capital expenditures	FY2024	$1.10B	New
Feb 6, 2024	EPS	FY2024	$18.90 – $20.30	New
Feb 6, 2024	EPS	FY2024	$8.42 – $9.87	New
Feb 6, 2024	tax rate	FY2024	11.5% – 13%	New
Feb 6, 2024	tax rate	FY2024	16% – 17%	New
Feb 6, 2024	Total revenues	FY2024	$32.40B – $33.80B	New
Oct 31, 2023	Capital expenditures	FY2023	$950.00M	Raised
Oct 31, 2023	EPS	FY2023	$18.20 – $18.80	Raised
Oct 31, 2023	EPS	FY2023	$11.23 – $12.73	Lowered
Oct 31, 2023	tax rate	FY2023	14% – 15.5%	Lowered
Oct 31, 2023	tax rate	FY2023	16.5% – 17%	Lowered
Oct 31, 2023	Share repurchases	FY2023	$500.00M	Reaffirmed
Oct 31, 2023	Total revenues	FY2023	$28.00B – $28.40B	Raised
Aug 3, 2023	Capital expenditures	FY2023	$925.00M	Reaffirmed
Aug 3, 2023	EPS	FY2023	$17.80 – $18.80	Raised
Aug 3, 2023	EPS	FY2023	$14.30 – $15.41	Lowered
Aug 3, 2023	tax rate	FY2023	17% – 18.5%	Reaffirmed
Aug 3, 2023	tax rate	FY2023	17.5% – 18.5%	Lowered
Aug 3, 2023	Share repurchases	FY2023	$500.00M	Reaffirmed
Aug 3, 2023	Total revenues	FY2023	$26.60B – $27.40B	Raised
Apr 27, 2023	Capital expenditures	FY2023	$925.00M	Reaffirmed
Apr 27, 2023	EPS	FY2023	$17.60 – $18.70	Raised
Apr 27, 2023	EPS	FY2023	$15.38 – $16.59	Raised
Apr 27, 2023	tax rate	FY2023	17% – 18.5%	Reaffirmed
Apr 27, 2023	tax rate	FY2023	18% – 19%	Reaffirmed
Apr 27, 2023	Share repurchases	FY2023	$500.00M	New
Apr 27, 2023	Total revenues	FY2023	$26.20B – $27.30B	Raised
Jan 31, 2023	Capital expenditures	FY2023	$925.00M	New
Jan 31, 2023	EPS	FY2023	$17.40 – $18.60	New
Jan 31, 2023	EPS	FY2023	$13.16 – $14.41	New
Jan 31, 2023	tax rate	FY2023	17% – 18.5%	New
Jan 31, 2023	tax rate	FY2023	18% – 19%	New
Jan 31, 2023	Total revenues	FY2023	$26.00B – $27.20B	New
Nov 3, 2022	Capital expenditures	FY2022	$950.00M	Reaffirmed
Nov 3, 2022	EPS	FY2022	$17.25 – $17.85	Narrowed
Nov 3, 2022	EPS	FY2022	$11.46 – $12.17	Raised
Nov 3, 2022	tax rate	FY2022	13.5% – 14.5%	Lowered
Nov 3, 2022	tax rate	FY2022	11% – 12.5%	Lowered
Nov 3, 2022	Share repurchases	FY2022	$6.00B – $7.00B	Reaffirmed
Nov 3, 2022	Total revenues	FY2022	$26.00B – $26.30B	Narrowed
Aug 4, 2022	Capital expenditures	FY2022	$950.00M	Reaffirmed
Aug 4, 2022	EPS	FY2022	$17.00 – $18.00	Reaffirmed
Aug 4, 2022	EPS	FY2022	$11.01 – $12.15	Lowered
Aug 4, 2022	tax rate	FY2022	11.5% – 13%	Raised
Aug 4, 2022	tax rate	FY2022	14% – 15%	Raised
Aug 4, 2022	Share repurchases	FY2022	$6.00B – $7.00B	Reaffirmed
Aug 4, 2022	Total revenues	FY2022	$25.50B – $26.40B	Narrowed
Apr 27, 2022	Capital expenditures	FY2022	$950.00M	New
Apr 27, 2022	EPS	FY2022	$17.00 – $18.00	New
Apr 27, 2022	EPS	FY2022	$12.53 – $13.58	New
Apr 27, 2022	tax rate	FY2022	10.5% – 12%	New
Apr 27, 2022	tax rate	FY2022	13.5% – 14.5%	New
Apr 27, 2022	Share repurchases	FY2022	$6.00B – $7.00B	New
Apr 27, 2022	Total revenues	FY2022	$25.40B – $26.50B	New
Nov 2, 2021	Capital expenditures	FY2021	$900.00M	New
Nov 2, 2021	EPS	FY2021	$16.50 – $17.10	New
Nov 2, 2021	EPS	FY2021	$9.55 – $10.21	New
Nov 2, 2021	tax rate	FY2021	12.5% – 14%	New
Nov 2, 2021	tax rate	FY2021	13% – 14%	New
Nov 2, 2021	Share repurchases	FY2021	$3.00B – $5.00B	New
Nov 2, 2021	Total revenues	FY2021	$25.80B – $26.20B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.